Mesenchymal stromal cell therapy for coronavirus disease 2019: which? when? and how much?

Cytotherapy · 2021 · PMC8084615 · PMID 34053857

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

[71] demonstrated a highly significant increase in TF expression in passage six versus passage three BM-MSCs, indicating a higher IBMIR-inducing capacity at higher passages.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.